Cassling signs two new VPs
Cassling Diagnostic Imaging started the new year by appointing two new vice presidents. The Omaha company named Gary Nie as vice president of its integrated services division and Kim Erb as vice president of sales.Nie will manage and develop CDI’s
Cassling Diagnostic Imaging started the new year by appointing two new vice presidents. The Omaha company named Gary Nie as vice president of its integrated services division and Kim Erb as vice president of sales.
Nie will manage and develop CDIs Integrated Equipment Solutions (IES) subsidiary, as well as Vision Imaging Components (VIC), a CT and x-ray tube manufacturer the company recently acquired. Previously director of equipment refurbishment for the firm, Nie worked to obtain ISO 9002 certification in IESs refurbishment division and expanded IES from 18,000 to 40,000 square feet.
Erb will concentrate on sales operations within the companys seven-state area of coverage and will manage CDIs 11 account executives, two applications specialists, and its image management director. A CDI employee since 1988, Erb helped grow the companys capital equipment sales by 80% over the last two years.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
